Michael Freeman, a psychiatrist and former CEO who serves on the faculty of the University of California San Francisco School of Medicine, investigated the prevalence and characteristics of mental health conditions among entrepreneurs. He concluded founders are twice as likely to suffer from depression, six times more likely to suffer from ADHD, three times more…

Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It’s a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved product. The company’s consumer marketing campaign for the EndeavorRx game centers on social media, while its distribution relies on a digital-first model. The consumer campaign,…

Methylphenidate hydrochloride (Adhansia XR) was originally approved in 2019 for ADHD patients at least 6 years old. The US Food and Drug Administration (FDA) has approved updated prescribing information for methylphenidate hydrochloride (Adhansia XR) extended-release capsules CII as a treatment for attention deficit/hyperactivity disorder (ADHD).

An analysis of data from the National Survey of Children’s Health for about 4000 children revealed that in children with attention-deficit/hyperactivity disorder (ADHD), participation in after-school activities is associated with decreased ADHD severity and less school absenteeism.

For the treatment of attention-deficit hyperactivity disorder (ADHD), one of the promising interventions is neurofeedback. In NEWROFEED, a prospective, multicentre, randomized (3:2), reference drug-controlled trial, researchers assessed the noninferiority of personalized at-home neurofeedback (NF) training vs methylphenidate in the treatment of children with ADHD…Read the full article on Journal of Child Psychology and Psychiatry.

Scientists explored a technique called ‘neurofeedback,’ which enables ADHD patients to train their attention, based on instant feedback from the level of their brain activity. The team of neuroscientists found that not only did the training have a positive effect on patients’ concentration abilities, but also that the attention improvement was closely linked to an…

Tests of a drug known to stimulate brain activity have shown early success in reducing symptoms of sluggish cognitive tempo in 38 men and women with attention deficit hyperactivity disorder (ADHD.)…Researchers at NYU Grossman School of Medicine and Icahn School of Medicine at Mount Sinai who led the study say the stimulant lisdexamfetamine (sold as…

On May 8th 2021, Dr Eugene Merzon, MD a certified ADHD Diagnostician and the head of department of managed and digital care of Leumit health service in Israel spoke at the 8th world congress of ADHD. Dr Merzon, stating that a high percentage of the ADHD patients were testing positive for Covid19. He postulated that…

Around one in 30 Australians (or 3.4% of the population) have attention-deficit hyperactivity disorder (ADHD). Yet it remains a poorly understood and highly stigmatized disorder. Our new paper, which reviews the research on community attitudes about ADHD, found misconceptions are common and affect the way people with ADHD are treated and see themselves.

KEY POINTS: A detailed ADHD plan considers a range of interventions. Flexible trial and error is one key to success. Stay proactive and consider everything from medication to meditation that may help with focus.

KEY POINTS: Procrastination and avoidance is often a key challenge for people with Adult ADHD. The thought of starting difficult tasks is not just unpleasant; it is painful. Therefore, pain centers activate when people think of a challenge. Using cognitive behavioral therapy and developing an action-oriented plan to meet goals can alleviate barriers.  

While methods vary, a majority of studies on the topic find significant demographic disparities in whose ADHD symptoms get missed or improperly diagnosed and treated. “Privilege plays a huge role in getting an ADHD diagnosis,” said Dr. Tumaini Rucker Coker, an associate professor of pediatrics at the University of Washington School of Medicine who researches…